# Multiple Dose Study to Evaluate Drug-drug Interactions, Safety and Tolerability of NDC-002 in Healthy Volunteers

> **NCT06090474** · PHASE1 · COMPLETED · sponsor: **Dr. Noah Biotech Inc.** · enrollment: 33 (actual)

## Conditions studied

- Stroke Sequelae
- Stroke

## Interventions

- **DRUG:** NDC-002

## Key facts

- **NCT ID:** NCT06090474
- **Lead sponsor:** Dr. Noah Biotech Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-12
- **Primary completion:** 2023-03-15
- **Final completion:** 2023-03-15
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2023-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06090474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06090474, "Multiple Dose Study to Evaluate Drug-drug Interactions, Safety and Tolerability of NDC-002 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06090474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*